US Patent Issued to Corcept Therapeutics on July 29 for "Formulations of dazucorilant, a glucocorticoid receptor modulator" (British, American Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,188, issued on July 29, was assigned to Corcept Therapeutics Inc. (Redwood City, Calif.).

"Formulations of dazucorilant, a glucocorticoid receptor modulator" was invented by Rick Bastin (Menlo Park, Calif.), Alla Hosny (Nottingham, Great Britain), Dolly Jacob (Nottingham, Great Britain) and Wu Lin (Nottingham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides formulations of (R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(pyridin-2-yl)methanone, and methods of making and using the same."

The patent was filed on Oct. 5, 2023, under A...